Our research aims to help identify the genetic determinants of complex human traits by using next-generation association studies to detect novel disease loci.
The overarching goal of our research is to elucidate the aetiopathological underpinnings of complex human disease. We carry out large-scale studies to investigate the genetic architecture of complex traits, with a primary focus on cardiometabolic and musculoskeletal phenotypes. In doing so, we identify and address statistical genetics challenges by designing, evaluating and proposing analytical strategies.
Advances in high-throughput genotyping and sequencing, coupled with the availability of large sample sets and a better understanding of human genome sequence variation, have made next-generation genetic studies feasible. It is widely accepted that, in the area of complex trait association studies, technology is in danger of outstripping our capacity to analyse and interpret the results obtained. The Analytical Genomics of Complex Traits group conducts next-generation association studies for complex phenotypes, such as type 2 diabetes, obesity and related metabolic traits, and develops appropriate robust methodologies to analyse and interpret the data where necessary.
Our research aims to:
- Identify novel complex trait loci by carrying out association studies;
- Develop, extend and make publicly available analytical tools;
- Understand the molecular mechanisms underpinning disease pathogenesis through functional genomics studies.
Our team conducts next generation genetic association studies in order to identify complex disease loci, and establishes robust analytical strategies to achieve this. We study the role of common, low frequency and rare sequence variants using different approaches. For example, we explore powerful ways to make use of the genetic homogeneity that characterises population isolates in order to identify low frequency variant associations. We also conduct studies to enhance our understanding of the allelic architecture and genetic heterogeneity attributes that underlie populations of African descent, for complex trait signal fine mapping and de novo discovery. Finally, we employ functional genomics approaches to better understand the molecular landscape of disease pathogenesis and to understand disease pathways.
List of key projects:
Genomics of population isolates
Population isolates have well-documented characteristics that can facilitate the detection of rare variants associated with complex traits, including reduced phenotypic, environmental and genetic heterogeneity. We are generating whole genome sequence data across well-phenotyped founder population cohorts (e.g. HELIC study) with a focus on medically relevant metabolic traits.
Genomics of African populations
Building on The African Genome Variation Project, which was set up to facilitate GWAS in African populations, the Uganda 2000 Genomes project has produced whole-genome sequence data on 2000 individuals and dense genotype data on 5000 individuals from Uganda with phenotypic information on more than 50 traits, including cardiometabolic, anthropometric, haematological, liver, renal function and infectious disease traits.
Body weight and fat distribution measures are associated with increased risk of cardiometabolic disease. As part of the UK10K study, we are exploring the contribution of low frequency variation to 12 anthropometric traits in up to 63,000 individuals with whole genome sequence or imputed data.
We carry out large-scale GWAS in diseases like osteoarthritis (e.g. arcOGEN study) and developmental dysplasia of the hip, and investigate the effect of rare variants through exome chip studies. We also examine radiograph-derived joint morphology traits, and have instigated novel patient collections with access to a wide range of relevant endophenotypes. We have applied functional genomics technologies (quantitative proteomics, RNA sequencing and methylation arrays) to articular chondrocytes from osteoarthritis patients undergoing total joint replacement with the aim of further characterising the genomic basis of disease and to inform the results of association studies.
We have an active interest in developing methods for the analysis of rare variants, estimating genome-wide significance thresholds for sequence-based studies and for studies in African populations, and work on developing methods and tools to interpret the functional consequences of sequence variants, including the GWAVA algorithm for annotating non-coding variants. We have been refining a variant calling and imputation pipeline for very low-depth sequence data, and are currently developing a meta-analysis method in the presence of sample relatedness or overlap.
We are part of a wide collaborative network and are actively involved in several national and international consortia: